Ai-wu Li

发表

Folate Receptor–Positive Circulating Tumor Cell Detected by LT-PCR–Based Method as a Diagnostic Biomarker for Non–Small-Cell Lung Cancer

Guohua Yang, S. Ren, Caicun Zhou, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Folate receptor-positive circulating tumor cells as a predictive biomarker for the efficacy of first-line pemetrexed-based chemotherapy in patients with non-squamous non-small cell lung cancer

Guohua Yang, S. Ren, Caicun Zhou, 2020, Annals of translational medicine.

Efficacy of first-line chemotherapy affects the second-line setting response in patients with advanced non-small cell lung cancer.

S. Ren, Caicun Zhou, G. Gao, 2014, Asian Pacific journal of cancer prevention : APJCP.

Feasibility of cytological specimens for ALK fusion detection in patients with advanced NSCLC using the method of RT-PCR.

T. Jiang, S. Ren, Caicun Zhou, 2016, Lung cancer.

Antibiotics are associated with attenuated efficacy of anti-PD-1/PD-L1 therapies in Chinese patients with advanced non-small cell lung cancer.

T. Jiang, S. Ren, Caicun Zhou, 2019, Lung cancer.

Folate receptor-positive circulating tumor cells as a predictive biomarker for the efficacy of first-line pemetrexed-based chemotherapy in patients with non-squamous non-small cell lung cancer

Guohua Yang, S. Ren, Caicun Zhou, 2019, Annals of Translational Medicine.

Comparison of vinorelbine, ifosfamide and cisplatin (NIP) and etoposide and cisplatin (EP) for treatment of advanced combined small cell lung cancer (cSCLC) patients: a retrospective study.

Jie Luo, Fengying Wu, Ai-wu Li, 2012, Asian Pacific journal of cancer prevention : APJCP.

A Case Report of Chemo-sensitive Intimal Pulmonary Artery Sarcoma

S. Ren, Caicun Zhou, Xiaoxia Chen, 2013, Cell Biochemistry and Biophysics.

Epithelial phenotype as a predictive marker for response to EGFR‐TKIs in non‐small cell lung cancer patients with wild‐type EGFR

Guotong Xu, S. Ren, Caicun Zhou, 2014, International Journal of Cancer.

Prognostic factors for survival in a Chinese population presenting with advanced non‐small cell lung cancer with an emphasis on smoking status: A regional, single‐institution, retrospective analysis of 4552 patients

S. Ren, Caicun Zhou, D. Garfield, 2012, Thoracic cancer.

Addition of bevacizumab for malignant pleural effusion as the manifestation of acquired EGFR-TKI resistance in NSCLC patients

T. Jiang, S. Ren, Caicun Zhou, 2017, Oncotarget.

A multicenter phase II study of sorafenib monotherapy in clinically selected patients with advanced lung adenocarcinoma after failure of EGFR-TKI therapy (Chinese Thoracic Oncology Group, CTONG 0805).

Ying Cheng, Yi-long Wu, Jin-Ji Yang, 2014, Lung cancer.

Epidermal growth factor receptor‐tyrosine kinase inhibitor therapy is effective as first‐line treatment of advanced non‐small‐cell lung cancer with mutated EGFR: A meta‐analysis from six phase III randomized controlled trials

Qinghua Xu, S. Ren, Caicun Zhou, 2012, International journal of cancer.

Gefitinib in the treatment of 41 cases with refractory non-small cell lung cancer

Caicun Zhou, Jian-fang Xu, Ai-wu Li, 2009 .

Association between Single Nucleotide Polymorphisms (SNPs) and Toxicity of Advanced Non-Small-Cell Lung Cancer Patients Treated with Chemotherapy

S. Ren, Caicun Zhou, G. Gao, 2012, PloS one.

Efficacy and Safety of ATA129, Partially Matched Allogeneic Third-Party Epstein-Barr Virus-Targeted Cytotoxic T Lymphocytes in a Multicenter Study for Post-Transplant Lymphoproliferative Disorder

S. Nikiforow, R. Baiocchi, K. Mahadeo, 2017 .

Individualized chemotherapy in advanced NSCLC patients based on mRNA levels of BRCA1 and RRM1

S. Ren, Caicun Zhou, Songwen Zhou, 2012, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Influence of comorbidity on the choice of treatment and survival of elderly patients with advanced non-small cell lung cancer

Caicun Zhou, Jie Luo, Jian-fang Xu, 2008 .

[Clinical characteristics and diagnosis of pulmonary mucosa-associated lymphoid tissue-derived (MALT) lymphoma: a retrospective analysis of 29 cases].

Caicun Zhou, Jian-fang Xu, Chun-yan Wu, 2012, Zhonghua zhong liu za zhi [Chinese journal of oncology].

Comparisons of curative and side effects of chemoradiotherapy among Xinjiang Han, Uigur and Kazakh esophageal carcinoma patients.

Mei Yang, Ai-wu Li, Li Zhang, 2012, Asian Pacific journal of cancer prevention : APJCP.

T790M mutation is associated with better efficacy of treatment beyond progression with EGFR-TKI in advanced NSCLC patients.

Jingyun Shi, S. Ren, Caicun Zhou, 2014, Lung cancer.

A Case Report of Chemo-sensitive Intimal Pulmonary Artery Sarcoma

S. Ren, Caicun Zhou, Xiaoxia Chen, 2013, Cell Biochemistry and Biophysics.

Folate Receptor-Positive Circulating tumor cell detected by LT-PCR based method as a diagnostic biomarker for non-small cell lung cancer.

Guohua Yang, S. Ren, Caicun Zhou, 2015 .

Combination chemotherapy with irinotecan and cisplatin as second-line treatment for small cell lung cancer

Caicun Zhou, Songwen Zhou, Jie Luo, 2008 .

Epithelial phenotype as a predictive marker for response to EGFR‐TKIs in non‐small cell lung cancer patients with wild‐type EGFR

Guotong Xu, S. Ren, Caicun Zhou, 2014, International journal of cancer.